Global Gastrointestinal Drugs Market Growth 2020-2025


Nov, 2020 | Report ID: 158360 | 165 | Pharmaceuticals and Healthcare

According to this study, over the next five years the Gastrointestinal Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Gastrointestinal Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Drugs market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Gastrointestinal Drugs, covering the supply chain analysis, impact assessment to the Gastrointestinal Drugs market size growth rate in several scenarios, and the measures to be undertaken by Gastrointestinal Drugs companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Prescription Gastrointestinal Drug

OTC Gastrointestinal Drug

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Chronic Gastritis

Functional Dyspepsia

Peptic Ulcer

Acute Gastroenteritis

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

AstraZeneca

Purdue Pharma

Sanofi

Pfizer

GlaxoSmithKline

Bayer

Perrigo

Teva

Boehringer Ingelheim

Zeria (Tillotts)

C.B. Fleet

Xian-Janssen

Jiangzhong

Abbott

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Gastrointestinal Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Gastrointestinal Drugs market by identifying its various subsegments.

Focuses on the key global Gastrointestinal Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Gastrointestinal Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Gastrointestinal Drugs submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gastrointestinal Drugs Consumption 2015-2025

2.1.2 Gastrointestinal Drugs Consumption CAGR by Region

2.2 Gastrointestinal Drugs Segment by Type

2.2.1 Prescription Gastrointestinal Drug

2.2.2 OTC Gastrointestinal Drug

2.3 Gastrointestinal Drugs Consumption by Type

2.3.1 Global Gastrointestinal Drugs Consumption Market Share by Type (2015-2020)

2.3.2 Global Gastrointestinal Drugs Revenue and Market Share by Type (2015-2020)

2.3.3 Global Gastrointestinal Drugs Sale Price by Type (2015-2020)

2.4 Gastrointestinal Drugs Segment by Application

2.4.1 Chronic Gastritis

2.4.2 Functional Dyspepsia

2.4.3 Peptic Ulcer

2.4.4 Acute Gastroenteritis

2.4.5 Other

2.5 Gastrointestinal Drugs Consumption by Application

2.5.1 Global Gastrointestinal Drugs Consumption Market Share by Type (2015-2020)

2.5.2 Global Gastrointestinal Drugs Value and Market Share by Type (2015-2020)

2.5.3 Global Gastrointestinal Drugs Sale Price by Type (2015-2020)

3 Global Gastrointestinal Drugs by Company

3.1 Global Gastrointestinal Drugs Sales Market Share by Company

3.1.1 Global Gastrointestinal Drugs Sales by Company (2018-2020)

3.1.2 Global Gastrointestinal Drugs Sales Market Share by Company (2018-2020)

3.2 Global Gastrointestinal Drugs Revenue Market Share by Company

3.2.1 Global Gastrointestinal Drugs Revenue by Company (2018-2020)

3.2.2 Global Gastrointestinal Drugs Revenue Market Share by Company (2018-2020)

3.3 Global Gastrointestinal Drugs Sale Price by Company

3.4 Global Gastrointestinal Drugs Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Gastrointestinal Drugs Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Gastrointestinal Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Gastrointestinal Drugs by Regions

4.1 Gastrointestinal Drugs by Regions

4.2 Americas Gastrointestinal Drugs Consumption Growth

4.3 APAC Gastrointestinal Drugs Consumption Growth

4.4 Europe Gastrointestinal Drugs Consumption Growth

4.5 Middle East & Africa Gastrointestinal Drugs Consumption Growth

5 Americas

5.1 Americas Gastrointestinal Drugs Consumption by Countries

5.1.1 Americas Gastrointestinal Drugs Consumption by Countries (2015-2020)

5.1.2 Americas Gastrointestinal Drugs Value by Countries (2015-2020)

5.2 Americas Gastrointestinal Drugs Consumption by Type

5.3 Americas Gastrointestinal Drugs Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Gastrointestinal Drugs Consumption by Regions

6.1.1 APAC Gastrointestinal Drugs Consumption by Regions (2015-2020)

6.1.2 APAC Gastrointestinal Drugs Value by Regions (2015-2020)

6.2 APAC Gastrointestinal Drugs Consumption by Type

6.3 APAC Gastrointestinal Drugs Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Gastrointestinal Drugs by Countries

7.1.1 Europe Gastrointestinal Drugs Consumption by Countries (2015-2020)

7.1.2 Europe Gastrointestinal Drugs Value by Countries (2015-2020)

7.2 Europe Gastrointestinal Drugs Consumption by Type

7.3 Europe Gastrointestinal Drugs Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Gastrointestinal Drugs by Countries

8.1.1 Middle East & Africa Gastrointestinal Drugs Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Gastrointestinal Drugs Value by Countries (2015-2020)

8.2 Middle East & Africa Gastrointestinal Drugs Consumption by Type

8.3 Middle East & Africa Gastrointestinal Drugs Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Gastrointestinal Drugs Distributors

10.3 Gastrointestinal Drugs Customer

11 Global Gastrointestinal Drugs Market Forecast

11.1 Global Gastrointestinal Drugs Consumption Forecast (2021-2025)

11.2 Global Gastrointestinal Drugs Forecast by Regions

11.2.1 Global Gastrointestinal Drugs Forecast by Regions (2021-2025)

11.2.2 Global Gastrointestinal Drugs Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast byRegions

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Gastrointestinal Drugs Forecast by Type

11.8 Global Gastrointestinal Drugs Forecast by Application

12 Key Players Analysis

12.1 AstraZeneca

12.1.1 Company Information

12.1.2 Gastrointestinal Drugs Product Offered

12.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 AstraZeneca Latest Developments

12.2 Purdue Pharma

12.2.1 Company Information

12.2.2 Gastrointestinal Drugs Product Offered

12.2.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Purdue Pharma Latest Developments

12.3 Sanofi

12.3.1 Company Information

12.3.2 Gastrointestinal Drugs Product Offered

12.3.3 Sanofi Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Sanofi Latest Developments

12.4 Pfizer

12.4.1 Company Information

12.4.2 Gastrointestinal Drugs Product Offered

12.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Pfizer Latest Developments

12.5 GlaxoSmithKline

12.5.1 Company Information

12.5.2 Gastrointestinal Drugs Product Offered

12.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 GlaxoSmithKline Latest Developments

12.6 Bayer

12.6.1 Company Information

12.6.2 Gastrointestinal Drugs Product Offered

12.6.3 Bayer Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Bayer Latest Developments

12.7 Perrigo

12.7.1 Company Information

12.7.2 Gastrointestinal Drugs Product Offered

12.7.3 Perrigo Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Perrigo Latest Developments

12.8 Teva

12.8.1 Company Information

12.8.2 Gastrointestinal Drugs Product Offered

12.8.3 Teva Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Teva Latest Developments

12.9 Boehringer Ingelheim

12.9.1 Company Information

12.9.2 Gastrointestinal Drugs Product Offered

12.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Boehringer Ingelheim Latest Developments

12.10 Zeria (Tillotts)

12.10.1 Company Information

12.10.2 Gastrointestinal Drugs Product Offered

12.10.3 Zeria (Tillotts) Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Zeria (Tillotts) Latest Developments

12.11 C.B. Fleet

12.11.1 Company Information

12.11.2 Gastrointestinal Drugs Product Offered

12.11.3 C.B. Fleet Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 C.B. Fleet Latest Developments

12.12 Xian-Janssen

12.12.1 Company Information

12.12.2 Gastrointestinal Drugs Product Offered

12.12.3 Xian-Janssen Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 Xian-Janssen Latest Developments

12.13 Jiangzhong

12.13.1 Company Information

12.13.2 Gastrointestinal Drugs Product Offered

12.13.3 Jiangzhong Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.13.4 Main Business Overview

12.13.5 Jiangzhong Latest Developments

12.14 Abbott

12.14.1 Company Information

12.14.2 Gastrointestinal Drugs Product Offered

12.14.3 Abbott Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.14.4 Main Business Overview

12.14.5 Abbott Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Gastrointestinal Drugs Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Prescription Gastrointestinal Drug

Table 5. Major Players of OTC Gastrointestinal Drug

Table 6. Global Consumption Sales by Type (2015-2020)

Table 7. Global Gastrointestinal Drugs Consumption Market Share by Type (2015-2020)

Table 8. Global Gastrointestinal Drugs Revenue by Type (2015-2020) ($ million)

Table 9. Global Gastrointestinal Drugs Value Market Share by Type (2015-2020) ($ Millions)

Table 10. Global Gastrointestinal Drugs Sale Price by Type (2015-2020)

Table 11. Global Consumption Sales by Application (2015-2020)

Table 12. Global Gastrointestinal Drugs Consumption Market Share by Application (2015-2020)

Table 13. Global Gastrointestinal Drugs Value by Application (2015-2020)

Table 14. Global Gastrointestinal Drugs Value Market Share by Application (2015-2020)

Table 15. Global Gastrointestinal Drugs Sale Price by Application (2015-2020)

Table 16. Global Gastrointestinal Drugs Sales by Company (2017-2019) (K Units)

Table 17. Global Gastrointestinal Drugs Sales Market Share by Company (2017-2019)

Table 18. Global Gastrointestinal Drugs Revenue by Company (2017-2019) ($ Millions)

Table 19. Global Gastrointestinal Drugs Revenue Market Share by Company (2017-2019)

Table 20. Global Gastrointestinal Drugs Sale Price by Company (2017-2019)

Table 21. Global Gastrointestinal Drugs Manufacturing Base Distribution and Sales Area by Manufacturers

Table 22. Players Gastrointestinal Drugs Products Offered

Table 23. Gastrointestinal Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 24. Global Gastrointestinal Drugs Consumption by Regions 2015-2020 (K Units)

Table 25. Global Gastrointestinal Drugs Consumption Market Share by Regions 2015-2020

Table 26. Global Gastrointestinal Drugs Value by Regions 2015-2020 ($ Millions)

Table 27. Global Gastrointestinal Drugs Value Market Share by Regions 2015-2020

Table 28. Americas Gastrointestinal Drugs Consumption by Countries (2015-2020) (K Units)

Table 29. Americas Gastrointestinal Drugs Consumption Market Share by Countries (2015-2020)

Table 30. Americas Gastrointestinal Drugs Value by Countries (2015-2020) ($ Millions)

Table 31. Americas Gastrointestinal Drugs Value Market Share by Countries (2015-2020)

Table 32. Americas Gastrointestinal Drugs Consumption by Type (2015-2020) (K Units)

Table 33. Americas Gastrointestinal Drugs Consumption Market Share by Type (2015-2020)

Table 34. Americas Gastrointestinal Drugs Consumption by Application (2015-2020) (K Units)

Table 35. Americas Gastrointestinal Drugs Consumption Market Share by Application (2015-2020)

Table 36. APAC Gastrointestinal Drugs Consumption by Regions (2015-2020) (K Units)

Table 37. APAC Gastrointestinal Drugs Consumption Market Share by Regions (2015-2020)

Table 38. APAC Gastrointestinal Drugs Value by Regions (2015-2020) ($ Millions)

Table 39. APAC Gastrointestinal Drugs Value Market Share by Regions (2015-2020)

Table 40. APAC Gastrointestinal Drugs Consumption by Type (2015-2020) (K Units)

Table 41. APAC Gastrointestinal Drugs Consumption Market Share by Type (2015-2020)

Table 42. APAC Gastrointestinal Drugs Consumption by Application (2015-2020) (K Units)

Table 43. APAC Gastrointestinal Drugs Consumption Market Share by Application (2015-2020)

Table 44. Europe Gastrointestinal Drugs Consumption by Countries (2015-2020) (K Units)

Table 45. Europe Gastrointestinal Drugs Consumption Market Share by Countries (2015-2020)

Table 46. Europe Gastrointestinal Drugs Value by Countries (2015-2020) ($ Millions)

Table 47. Europe Gastrointestinal Drugs Value Market Share by Countries (2015-2020)

Table 48. Europe Gastrointestinal Drugs Consumption by Type (2015-2020) (K Units)

Table 49. Europe Gastrointestinal Drugs Consumption Market Share by Type (2015-2020)

Table 50. Europe Gastrointestinal Drugs Consumption by Application (2015-2020) (K Units)

Table 51. Europe Gastrointestinal Drugs Consumption Market Share by Application (2015-2020)

Table 52. Middle East & Africa Gastrointestinal Drugs Consumption by Countries (2015-2020) (K Units)

Table 53. Middle East & Africa Gastrointestinal Drugs Consumption Market Share by Countries (2015-2020)

Table 54. Middle East & Africa Gastrointestinal Drugs Value by Countries (2015-2020) ($ Millions)

Table 55. Middle East & Africa Gastrointestinal Drugs Value Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Gastrointestinal Drugs Consumption by Type (2015-2020) (K Units)

Table 57. Middle East & Africa Gastrointestinal Drugs Consumption Market Share by Type (2015-2020)

Table 58. Middle East & Africa Gastrointestinal Drugs Consumption by Application (2015-2020) (K Units)

Table 59. Middle East & Africa Gastrointestinal Drugs Consumption Market Share by Application (2015-2020)

Table 60. Gastrointestinal Drugs Distributors List

Table 61. Gastrointestinal Drugs Customer List

Table 62. Global Gastrointestinal Drugs Consumption Forecast by Countries (2021-2025) (K Units)

Table 63. Global Gastrointestinal Drugs Consumption Market Forecast by Regions

Table 64. Global Gastrointestinal Drugs Value Forecast by Countries (2021-2025) ($ Millions)

Table 65. Global Gastrointestinal Drugs Value Market Share Forecast by Regions

Table 66. Global Gastrointestinal Drugs Consumption Forecast by Type (2021-2025) (K Units)

Table 67. Global Gastrointestinal Drugs Consumption Market Share Forecast by Type (2021-2025)

Table 68. Global Gastrointestinal Drugs Value Forecast by Type (2021-2025) ($ Millions)

Table 69. Global Gastrointestinal Drugs Value Market Share Forecast by Type (2021-2025)

Table 70. Global Gastrointestinal Drugs Consumption Forecast by Application (2021-2025) (K Units)

Table 71. Global Gastrointestinal Drugs Consumption Market Share Forecast by Application (2021-2025)

Table 72. Global Gastrointestinal Drugs Value Forecast by Application (2021-2025) ($ Millions)

Table 73. Global Gastrointestinal Drugs Value Market Share Forecast by Application (2021-2025)

Table 74. AstraZeneca Product Offered

Table 75. AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 76. AstraZeneca Main Business

Table 77. AstraZeneca Latest Developments

Table 78. AstraZeneca Basic Information, Company Total Revenue (in $ million), Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 79. Purdue Pharma Product Offered

Table 80. Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 81. Purdue Pharma Main Business

Table 82. Purdue Pharma Latest Developments

Table 83. Purdue Pharma Basic Information, Company Total Revenue (in $ million), Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 84. Sanofi Product Offered

Table 85. Sanofi Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 86. Sanofi Main Business

Table 87. Sanofi Latest Developments

Table 88. Sanofi Basic Information, Company Total Revenue (in $ million), Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 89. Pfizer Product Offered

Table 90. Pfizer Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 91. Pfizer Main Business

Table 92. Pfizer Latest Developments

Table 93. Pfizer Basic Information, Company Total Revenue (in $ million), Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 94. GlaxoSmithKline Product Offered

Table 95. GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 96. GlaxoSmithKline Main Business

Table 97. GlaxoSmithKline Latest Developments

Table 98. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 99. Bayer Product Offered

Table 100. Bayer Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 101. Bayer Main Business

Table 102. Bayer Latest Developments

Table 103. Bayer Basic Information, Company Total Revenue (in $ million), Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 104. Perrigo Product Offered

Table 105. Perrigo Basic Information, Company Total Revenue (in $ million), Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. Perrigo Main Business

Table 107. Perrigo Latest Developments

Table 108. Perrigo Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 109. Teva Product Offered

Table 110. Teva Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 111. Teva Main Business

Table 112. Teva Latest Developments

Table 113. Teva Basic Information, Company Total Revenue (in $ million), Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 114. Boehringer Ingelheim Product Offered

Table 115. Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 116. Boehringer Ingelheim Main Business

Table 117. Boehringer Ingelheim Latest Developments

Table 118. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 119. Zeria (Tillotts) Product Offered

Table 120. Zeria (Tillotts) Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 121. Zeria (Tillotts) Main Business

Table 122. Zeria (Tillotts) Latest Developments

Table 123. Zeria (Tillotts) Basic Information, Company Total Revenue (in $ million), Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 124. C.B. Fleet Product Offered

Table 125. C.B. Fleet Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 126. C.B. Fleet Main Business

Table 127. C.B. Fleet Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 128. C.B. Fleet Latest Developments

Table 129. Xian-Janssen Product Offered

Table 130. Xian-Janssen Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 131. Xian-Janssen Main Business

Table 132. Xian-Janssen Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 133. Xian-Janssen Latest Developments

Table 134. Jiangzhong Product Offered

Table 135. Jiangzhong Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 136. Jiangzhong Main Business

Table 137. Jiangzhong Latest Developments

Table 138. Jiangzhong Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 139. Abbott Product Offered

Table 140. Abbott Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 141. Abbott Main Business

Table 142. Abbott Latest Developments

Table 143. Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Gastrointestinal Drugs

Figure 2. Gastrointestinal Drugs Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Gastrointestinal Drugs Consumption Growth Rate 2015-2025 (K Units)

Figure 5. Global Gastrointestinal Drugs Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Prescription Gastrointestinal Drug

Figure 7. Product Picture of OTC Gastrointestinal Drug

Figure 8. Global Gastrointestinal Drugs Consumption Market Share by Type (2015-2020)

Figure 9. Global Gastrointestinal Drugs Value Market Share by Type (2015-2020)

Figure 10. Gastrointestinal Drugs Consumed in Chronic Gastritis

Figure 11. Global Gastrointestinal Drugs Market: Chronic Gastritis (2015-2020) (K Units)

Figure 12. Global Gastrointestinal Drugs Market: Chronic Gastritis (2015-2020) ($ Millions)

Figure 13. Gastrointestinal Drugs Consumed in Functional Dyspepsia

Figure 14. Global Gastrointestinal Drugs Market: Functional Dyspepsia (2015-2020) (K Units)

Figure 15. Global Gastrointestinal Drugs Market: Functional Dyspepsia (2015-2020) ($ Millions)

Figure 16. Gastrointestinal Drugs Consumed in Peptic Ulcer

Figure 17. Global Gastrointestinal Drugs Market: Peptic Ulcer (2015-2020) (K Units)

Figure 18. Global Gastrointestinal Drugs Market: Peptic Ulcer (2015-2020) ($ Millions)

Figure 19. Gastrointestinal Drugs Consumed in Acute Gastroenteritis

Figure 20. Global Gastrointestinal Drugs Market: Acute Gastroenteritis (2015-2020) (K Units)

Figure 21. Global Gastrointestinal Drugs Market: Acute Gastroenteritis (2015-2020) ($ Millions)

Figure 22. Gastrointestinal Drugs Consumed in Other

Figure 23. Global Gastrointestinal Drugs Market: Other (2015-2020) (K Units)

Figure 24. Global Gastrointestinal Drugs Market: Other (2015-2020) ($ Millions)

Figure 25. Global Gastrointestinal Drugs Consumption Market Share by Application (2015-2020)

Figure 26. Global Gastrointestinal Drugs Value Market Share by Application (2015-2020)

Figure 27. Global Gastrointestinal Drugs Sales Market Share by Company in 2017

Figure 28. Global Gastrointestinal Drugs Sales Market Share by Company in 2019

Figure 29. Global Gastrointestinal Drugs Revenue Market Share by Company in 2017

Figure 30. Global Gastrointestinal Drugs Revenue Market Share by Company in 2019

Figure 31. Global Gastrointestinal Drugs Sale Price by Company in 2019

Figure 32. Global Gastrointestinal Drugs Consumption Market Share by Regions 2015-2020

Figure 33. Global Gastrointestinal Drugs Value Market Share by Regions 2015-2020

Figure 34. Americas Gastrointestinal Drugs Consumption 2015-2020 (K Units)

Figure 35. Americas Gastrointestinal Drugs Value 2015-2020 ($ Millions)

Figure 36. APAC Gastrointestinal Drugs Consumption 2015-2020 (K Units)

Figure 37. APAC Gastrointestinal Drugs Value 2015-2020 ($ Millions)

Figure 38. Europe Gastrointestinal Drugs Consumption 2015-2020 (K Units)

Figure 39. Europe Gastrointestinal Drugs Value 2015-2020 ($ Millions)

Figure 40. Middle East & Africa Gastrointestinal Drugs Consumption 2015-2020 (K Units)

Figure 41. Middle East & Africa Gastrointestinal Drugs Value 2015-2020 ($ Millions)

Figure 42. Americas Gastrointestinal Drugs Consumption Market Share by Countries in 2019

Figure 43. Americas Gastrointestinal Drugs Value Market Share by Countries in 2019

Figure 44. Americas Gastrointestinal Drugs Consumption Market Share by Type in 2019

Figure 45. Americas Gastrointestinal Drugs Consumption Market Share by Application in 2019

Figure 46. United States Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 47. United States Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 48. Canada Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 49. Canada Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 50. Mexico Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 51. Mexico Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 52. APAC Gastrointestinal Drugs Consumption Market Share by Countries in 2019

Figure 53. APAC Gastrointestinal Drugs Value Market Share by Regions in 2019

Figure 54. APAC Gastrointestinal Drugs Consumption Market Share by Type in 2019

Figure 55. APAC Gastrointestinal Drugs Consumption Market Share by Application in 2019

Figure 56. China Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 57. China Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 58. Japan Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 59. Japan Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 60. Korea Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 61. Korea Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 62. Southeast Asia Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 63. Southeast Asia Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 64. India Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 65. India Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 66. Australia Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 67. Australia Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 68. Europe Gastrointestinal Drugs Consumption Market Share by Countries in 2019

Figure 69. Europe Gastrointestinal Drugs Value Market Share by Countries in 2019

Figure 70. Europe Gastrointestinal Drugs Consumption Market Share by Type in 2019

Figure 71. Europe Gastrointestinal Drugs Consumption Market Share by Application in 2019

Figure 72. Germany Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 73. Germany Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 74. France Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 75. France Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 76. UK Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 77. UK Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 78. Italy Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 79. Italy Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 80. Russia Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 81. Russia Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 82. Middle East & Africa Gastrointestinal Drugs Consumption Market Share by Countries in 2019

Figure 83. Middle East & Africa Gastrointestinal Drugs Value Market Share by Countries in 2019

Figure 84. Middle East & Africa Gastrointestinal Drugs Consumption Market Share by Type in 2019

Figure 85. Middle East & Africa Gastrointestinal Drugs Consumption Market Share by Application in 2019

Figure 86. Egypt Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 87. Egypt Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 88. South Africa Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 89. South Africa Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 90. Israel Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 91. Israel Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 92. Turkey Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 93. Turkey Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 94. GCC Countries Gastrointestinal Drugs Consumption Growth 2015-2020 (K Units)

Figure 95. GCC Countries Gastrointestinal Drugs Value Growth 2015-2020 ($ Millions)

Figure 96. Global Gastrointestinal Drugs Consumption Growth Rate Forecast (2021-2025) (K Units)

Figure 97. Global Gastrointestinal Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 98. Americas Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 99. Americas Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 100. APAC Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 101. APAC Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 102. Europe Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 103. Europe Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 104. Middle East & Africa Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 105. Middle East & Africa Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 106. United States Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 107. United States Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 108. Canada Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 109. Canada Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 110. Mexico Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 111. Mexico Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 112. Brazil Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 113. Brazil Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 114. China Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 115. China Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 116. Japan Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 117. Japan Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 118. Korea Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 119. Korea Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 120. Southeast Asia Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 121. Southeast Asia Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 122. India Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 123. India Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 124. Australia Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 125. Australia Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 126. Germany Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 127. Germany Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 128. France Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 129. France Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 130. UK Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 131. UK Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 132. Italy Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 133. Italy Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 134. Russia Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 135. Russia Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 136. Spain Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 137. Spain Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 138. Egypt Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 139. Egypt Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 140. South Africa Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 141. South Africa Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 142. Israel Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 143. Israel Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 144. Turkey Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 145. Turkey Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 146. GCC Countries Gastrointestinal Drugs Consumption 2021-2025 (K Units)

Figure 147. GCC Countries Gastrointestinal Drugs Value 2021-2025 ($ Millions)

Figure 148. AstraZeneca Gastrointestinal Drugs Market Share (2018-2020)

Figure 149. Purdue Pharma Gastrointestinal Drugs Market Share (2018-2020)

Figure 150. Sanofi Gastrointestinal Drugs Market Share (2018-2020)

Figure 151. Pfizer Gastrointestinal Drugs Market Share (2018-2020)

Figure 152. GlaxoSmithKline Gastrointestinal Drugs Market Share (2018-2020)

Figure 153. Bayer Gastrointestinal Drugs Market Share (2018-2020)

Figure 154. Perrigo Gastrointestinal Drugs Market Share (2018-2020)

Figure 155. Teva Gastrointestinal Drugs Market Share (2018-2020)

Figure 156. Boehringer Ingelheim Gastrointestinal Drugs Market Share (2018-2020)

Figure 157. Zeria (Tillotts) Gastrointestinal Drugs Market Share (2018-2020)

Figure 158. C.B. Fleet Gastrointestinal Drugs Market Share (2018-2020)

Figure 159. Xian-Janssen Gastrointestinal Drugs Market Share (2018-2020)

Figure 160. Jiangzhong Gastrointestinal Drugs Market Share (2018-2020)

Figure 161. Abbott Gastrointestinal Drugs Market Share (2018-2020)

Sample Request is not available